Ingevity Corp
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
NGVT$60.78-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Operations (Unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| In millions, except per share data | 2025 | 2024 |
| Net sales | $284.0 | $340.1 |
| Cost of sales | 170.6 | 240.4 |
| Gross profit | 113.4 | 99.7 |
| Selling, general, and administrative expenses | 43.1 | 47.2 |
| Research and technical expenses | 7.7 | 6.8 |
| Restructuring and other (income) charges, net | 12.3 | 62.8 |
| Acquisition-related costs | — | 0.3 |
| Other (income) expense, net | 4.1 | 32.2 |
| Interest expense, net | 19.4 | 22.3 |
| Income (loss) before income taxes | 26.8 | (71.9) |
| Provision (benefit) for income taxes | 6.3 | (15.9) |
| Net income (loss) | $20.5 | $(56.0) |
| Per share data | ||
| Basic earnings (loss) per share | $0.56 | $(1.54) |
| Diluted earnings (loss) per share | 0.56 | (1.54) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.